Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
5.70
+0.36 (6.74%)
At close: Feb 6, 2026, 4:00 PM EST
5.81
+0.11 (1.93%)
After-hours: Feb 6, 2026, 6:52 PM EST
Cadrenal Therapeutics Market Cap
Cadrenal Therapeutics has a market cap or net worth of $13.33 million as of February 6, 2026. Its market cap has decreased by -62.22% in one year.
Market Cap
13.33M
Enterprise Value
9.47M
1-Year Change
-62.22%
Ranking
Category
Stock Price
$5.70
Market Cap Chart
Since the IPO on January 20, 2023, Cadrenal Therapeutics's market cap has decreased from $58.17M to $13.33M, a decrease of -77.09%. That is a compound annual growth rate of -38.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 13.33M | -15.93% |
| Dec 31, 2025 | 15.85M | -38.62% |
| Dec 31, 2024 | 25.83M | 168.05% |
| Dec 29, 2023 | 9.64M | -83.44% |
| Jan 20, 2023 | 58.17M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CytoMed Therapeutics | 13.50M |
| BioAtla | 13.49M |
| Cocrystal Pharma | 13.37M |
| Allarity Therapeutics | 13.36M |
| Curis | 13.32M |
| Moleculin Biotech | 13.27M |
| BioCardia | 13.27M |
| Cellectar Biosciences | 12.89M |